OCCLUDER
STRUCTURAL INTERVENTIONS
The primary treatment option for atrial septal defects (ASD) is percutaneous,
transcatheter closure, and Abbott’s Amplatzer™ Septal Occluder is the proven
standard of care2,5—with more than 20 years of global clinical experience in ASD closure.1
FROM THE #1 COMPANY IN CONGENITAL OCCLUDERS1
The Amplatzer™ line not only pioneered structural heart defect occluder devices, it remains the leader in innovation and treatment worldwide. The Amplatzer Septal Occluder offers exceptional safety data, which is significant given that it is the most studied transcatheter ASD closure device on the market.9
500,000+
AMPLATZER™ SEPTAL
OCCLUDER DEVICES SOLD1
1,900+
PATIENTS STUDIED3, 4, 8
750+
PEER-REVIEWED
ARTICLES
TREATMENT RANGE 4 MM TO 40 MM
No other ASD closure device on the market today can match ASO’s wide range of device sizes.
AVAILABLE IN
27 DIFFERENT SIZES3
Ranging from 4 mm to 40 mm, designed to treat most patient anatomies and constructed to accommodate various septal morphologies.
The Amplatzer™ Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on respective Instructions for Use.
TV
TV
Left Atrial Appendage Occlusion (LAAO)
Anatomical overview of the heart
ASD Patient Story: Valeria
Echo course ASD
Amplatzer™ manufacturing video: nitinol
- Data on file at Abbott.
- Kashour TS, Latroche B, Elhoury ME, et al. Successful percutaneous closure of a secundum atrial septal defect through femoral approach in a patient with interrupted inferior vena cava. Congenit Heart Dis. 2010;5:620–623.
- ARTMT600149465_C ASO IFU MDR
- Turner DR, Owada CY, Sang Jr. CJ, Khan M, Lim S. Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study. Circulation: Cardiovascular Interventions. 2017;10(8):1-7.
- Tadros VX, Asgar AW. Transcatheter closure of atrial septal defects: an update on ASD occlusion devices. Card Interv Today. 2016; March-April.
- Amplatzer Septal Occluder Instructions for Use.
- Cho MJ, Song J, Kim SJ, et al. Transcatheter closure of multiple atrial septal defects with the Amplatzer™ device. Korean Circ J. 2011;41:549-551.
- Everett AD, Jennings J, Sibinga E, et al. Community use of the Amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol. 2009;30:240-247.
- Baumgartner, H., et al., 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J, 2021. 42(6): p. 563-645.
- Amplatzer Multi-Fenestrated Septal Occluder - Cribriform Instructions for Use.